While millions of people worldwide await the launch of an HIV vaccine, the U.S. government recently took action by committing to fund early-stage vaccine candidates.
On April 26, 2023, Uvax Bio, LLC announced that its HIV vaccine candidates had shown significantly improved immune response compared with current vaccine strategies.
Read More
